Scientific Findings: Cancer and Skin Toxicity

December 05, 2020

San Francisco, CA (UCSF Department of DermatologyOriginal Article) April 20th, 2009

Abstract: As inhibitors of the epidermal growth factor receptor (EGFR) become an increasingly common therapeutic option in cancer, appropriate management of their associated toxicities emerges as a critical part of treatment. Cutaneous manifestations, probably linked to the function of the EGFR in epithelial development, are the most common adverse reactions to EGFR inhibition. The key manifestations are follicular eruptions, nail disorders, xerosis, and desquamation. Growing attention continues to be devoted to the analysis of these events, particularly given their potential role as markers of responsiveness to treatment. However, to date, there are few evidence-based guidelines for the appropriate management of these dermatologic events. Multidisciplinary collaboration between oncologists and dermatologists will be required to improve our understanding and optimize the characterization of these skin toxicities, and to design effective management approaches. Read More

published April 20th, 2006

 




Also in News

Understanding Alcohol in Skincare. Not all alcohols are what you may think.

July 28, 2021

When we hear, "alcohol" most people think of rubbing alcohol (isopropyl) or alcoholic beverages (ethanol).  When employed in personal care products, it is often erroneously assumed that all alcohols are drying to the skin.

Read More

Eye melanoma risk factors

December 07, 2020

Read More

Some Women’s Preventive Services Now Covered Without Co-Payment

December 07, 2020

Read More